Skip to main content
Caplight Logo









Shinsei Capital Partners

Shinsei Capital Partners

Overview

Shinsei Capital Partners is a Japanese venture capital firm, carved out from the Shinsei Bank Group, that specializes in investing in life science companies including drug discovery and digital health.

Year Founded

2018

Portfolio Companies

13

Investments

Shinsei Capital Partners investments
CompanyDateStageLead
AlphaNavi Pharma Inc.Mar 2023Series BCo-investor
Luxna Biotech Co., Ltd.Dec 2021DebtCo-investor
Promethera BiosciencesMay 2019Series DLead
Metcela Inc.Jun 2022Series C-
Junten Bio Co., Ltd.Jun 2019SeedCo-investor
Book a demo to see all 13 portfolio companies

For institutional investors. Book with your work email.

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Shinsei Capital Partners based?

Shinsei Capital Partners is headquartered in Tokyo, Japan.

When was Shinsei Capital Partners founded?

Shinsei Capital Partners was founded in 2018.

How many portfolio companies does Shinsei Capital Partners have?

Shinsei Capital Partners has 13 portfolio companies in Caplight's dataset.

What are some companies in Shinsei Capital Partners's portfolio?

Portfolio companies visible on Caplight include AlphaNavi Pharma Inc., Luxna Biotech Co., Ltd., Promethera Biosciences, Metcela Inc., Junten Bio Co., Ltd..

What was Shinsei Capital Partners's most recent investment shown here?

Shinsei Capital Partners's most recent investment in this portfolio sample was in AlphaNavi Pharma Inc. in 2023.

What sectors does Shinsei Capital Partners focus on?

Shinsei Capital Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Enterprise Software, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.

What company stages does Shinsei Capital Partners focus on?

Shinsei Capital Partners typically invests at the MultiStage stage.

What is Shinsei Capital Partners's AUM?

Shinsei Capital Partners's assets under management are estimated between $67.3M and $67.3M.

Firmographic Details

HeadquartersTokyo
Year Founded2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?